{"entity":{"type":"insider","cik":"0001710969","url":"/insider/0001710969","json_url":"/insider/0001710969.json","name":"Reumuth Mary","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":13,"first":"2021-06-29","last":"2025-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Reumuth Mary","source":"filing","n_filings":13,"first_seen":"2021-06-29","last_seen":"2025-10-24"}],"transactions":[{"id":5115959,"accession":"0001710969-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001710969-25-000003","line_url":"/filing/0001710969-25-000003#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":967.0,"shares_display":"967","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":792.94,"total_display":"792.94","total_whole":"793","shares_owned_after":28906.0,"shares_owned_after_display":"28,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-23","filed_date":"2025-10-24","scope":"insider"},{"id":5115955,"accession":"0001710969-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001710969-25-000003","line_url":"/filing/0001710969-25-000003#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32230.0,"shares_display":"32,230","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":26750.9,"total_display":"26,750.90","total_whole":"26,751","shares_owned_after":29873.0,"shares_owned_after_display":"29,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-22","filed_date":"2025-10-24","scope":"insider"},{"id":4589918,"accession":"0001415889-25-018320","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-018320","line_url":"/filing/0001415889-25-018320#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3631.0,"shares_display":"3,631","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":14560.31,"total_display":"14,560.31","total_whole":"14,560","shares_owned_after":62100.0,"shares_owned_after_display":"62,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":4281354,"accession":"0001415889-25-015680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015680","line_url":"/filing/0001415889-25-015680#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":10659.0,"total_display":"10,659.00","total_whole":"10,659","shares_owned_after":65731.0,"shares_owned_after_display":"65,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-04","scope":"insider"},{"id":4804869,"accession":"0001415889-25-001059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001059","line_url":"/filing/0001415889-25-001059#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1706.0,"shares_display":"1,706","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":13016.78,"total_display":"13,016.78","total_whole":"13,017","shares_owned_after":68581.0,"shares_owned_after_display":"68,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2806755,"accession":"0001415889-24-018375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-018375","line_url":"/filing/0001415889-24-018375#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4163.0,"shares_display":"4,163","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":19774.25,"total_display":"19,774.25","total_whole":"19,774","shares_owned_after":60187.0,"shares_owned_after_display":"60,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-27","scope":"insider"},{"id":2043699,"accession":"0001415889-24-015224","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015224","line_url":"/filing/0001415889-24-015224#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1786.0,"shares_display":"1,786","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":10876.74,"total_display":"10,876.74","total_whole":"10,877","shares_owned_after":64350.0,"shares_owned_after_display":"64,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-03","scope":"insider"},{"id":2995334,"accession":"0001415889-24-000767","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000767","line_url":"/filing/0001415889-24-000767#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1227.0,"shares_display":"1,227","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":8269.98,"total_display":"8,269.98","total_whole":"8,270","shares_owned_after":66136.0,"shares_owned_after_display":"66,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":8515767,"accession":"0001415889-23-000639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-000639","line_url":"/filing/0001415889-23-000639#line-2","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60.0,"shares_display":"60","price_per_share":28.54,"price_display":"28.54","price_state":"stated","total_value":1712.4,"total_display":"1,712.40","total_whole":"1,712","shares_owned_after":11883.0,"shares_owned_after_display":"11,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6382640,"accession":"0001415889-22-010880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-010880","line_url":"/filing/0001415889-22-010880#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194.0,"shares_display":"194","price_per_share":6.51,"price_display":"6.51","price_state":"stated","total_value":1262.94,"total_display":"1,262.94","total_whole":"1,263","shares_owned_after":2418.0,"shares_owned_after_display":"2,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6666027,"accession":"0001415889-22-007062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-007062","line_url":"/filing/0001415889-22-007062#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2613.0,"shares_display":"2,613","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":966.81,"total_display":"966.81","total_whole":"967","shares_owned_after":130595.0,"shares_owned_after_display":"130,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6528102,"accession":"0001415889-22-000405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-000405","line_url":"/filing/0001415889-22-000405#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":3705.0,"total_display":"3,705.00","total_whole":"3,705","shares_owned_after":133208.0,"shares_owned_after_display":"133,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":5220535,"accession":"0001415889-21-005012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005012","line_url":"/filing/0001415889-21-005012#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9449.0,"shares_display":"9,449","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":17008.2,"total_display":"17,008.20","total_whole":"17,008","shares_owned_after":136058.0,"shares_owned_after_display":"136,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":4544916,"accession":"0001415889-21-003259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-003259","line_url":"/filing/0001415889-21-003259#line-1","is_derivative":false,"issuer_cik":"0001479419","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001479419","owner_cik":"0001710969","owner_name":"Reumuth Mary","owner_display_name":"Reumuth Mary","owner_url":"/insider/0001710969","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2452.0,"shares_display":"2,452","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":14148.04,"total_display":"14,148.04","total_whole":"14,148","shares_owned_after":145507.0,"shares_owned_after_display":"145,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"KALA BIO, Inc.","url":"/issuer/0001479419","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":13,"first_seen":"2021-06-29","last_seen":"2025-10-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001710969","retrieved_at":"2026-08-23T00:56:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}